LPL has potential as a biomarker for cancer diagnosis and prognosis. Elevated levels of LPL have been observed in the serum of patients with certain types of cancer. For instance, higher serum LPL activity has been correlated with poor prognosis in breast cancer patients. Therefore, measuring LPL levels could aid in early cancer detection and in assessing the aggressiveness of the disease.
